Michigan Biosciences Industry Association Logo

Federal Advocacy

Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
Congressional Advocates Seek Expedited Disbursement of Critical NIH Funding
Posted In: Federal Advocacy,
Date posted Jul 29

U.S. Senator Katie Britt (R-AL), a member of the Senate Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related...

Read Post
SBIR/STTR Reauthorization Update: Legislative Efforts Intensify as Program Deadline Approaches
Posted In: Federal Advocacy,
Date posted Jul 29

As the September 30, 2025 sunset date looms for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR)...

Read Post
Controversial New Patent Fee Model Emerges
Posted In: Federal Advocacy,
Date posted Jul 29

The Trump administration, according to a July 28, 2025 Wall Street Journal article (subscription-based), is reportedly exploring a major overhaul...

Read Post
Key Measures for Biosciences Industry Still Being Debated as OBBBA Inches Forward
Posted In: Federal Advocacy,
Date posted Jul 1

The "One Big Beautiful Bill" is a piece of legislation currently being debated in Congress that among many other items, includes provisions...

Read Post
Trump Administration Issues EO Invoking a Most Favored Nation (MFN) Drug Pricing Policy
Posted In: Federal Advocacy,
Date posted May 21

In the ongoing debate over soaring prescription drug costs in the United States, one policy proposal has gained significant attention: the...

Read Post
Patent Eligibility Restoration Act (PERA) Reintroduced
Posted In: Federal Advocacy,
Date posted May 21

U.S. Senators Thom Tillis (R-NC), Chairman of the Senate Judiciary Subcommittee on Intellectual Property, and Chris Coons (D-DE), and...

Read Post
Citizen Petition Filed Against FDA's Call for Animal Testing Alternatives
Posted In: Federal Advocacy,
Date posted May 9

A citizen petition has been filed objecting to the FDA's recent call for alternatives to animal testing, arguing that it could lead to reliance on...

Read Post
NIH Issues Rules Banning DEI Activities
Posted In: Federal Advocacy,
Date posted Apr 24

The National Institutes of Health (NIH) has implemented new grant policies that prohibit funding for researchers and institutions engaged in...

Read Post
Reports Document FDA Review Delays: What It Means for Drug Manufacturers
Posted In: Federal Advocacy,
Date posted Apr 24

Recent reports have highlighted growing concerns over delays in the U.S. Food and Drug Administration's (FDA) drug review processes, particularly...

Read Post
Amid Proposed Cuts, Commission Calls For $15B NIH Support
Posted In: Federal Advocacy,
Date posted Apr 11

A federal commission, in a new report, is calling for $15 billion in new financing to reinforce the United States’ biotech leadership amid...

Read Post
Pause in Tariff Implementation Welcomed by Medtech Sector
Posted In: Federal Advocacy,
Date posted Apr 11

AdvaMed, a national medical device trade organization, of which MichBio is a state affiliate, applauded in a press release, the Trump...

Read Post
New Report on Where NIH Funding Cuts Would Hit Hardest
Posted In: Federal Advocacy,
Date posted Apr 11

According to the Science and Community Impact Mapping Project (SCIMaP), proposed NIH funding cuts could lead to $16 billion in economic loss and...

Read Post